HippoFi 43a.webp

Dr. Gail Naughton, world-renowned authority on the multi-billion dollar regenerative medicine market, joins HippoFi as Head of Regenerative Therapeutics and Commercialization

 

Scientist, inventor, business expert and holder of more than 140 patents will advance PUR Biologics’ regenerative therapeutic patent portfolio to address unmet needs in the $200 billion osteoarthritis, pain and cartilage and spine regeneration markets.

IRVINE CA., November 7, 2023 – OrthoSpineNews – HippoFi, Inc. (OTCPK: ORHB) is proud to announce the appointment of the world’s foremost authority and pioneer in regenerative medicine, Gail Naughton, MBA, Ph.D, as the “Head of Regenerative Therapeutics and Commercialization.”

Recognized worldwide, Dr. Naughton was awarded the 27th annual National Inventor of the Year by the Intellectual Property Owners Association in honor of her groundbreaking work in tissue engineering and regenerative medicine. Dr. Naughton has been a driving force in regenerative medicine for more than 35 years and, as founder of Advanced Tissue Sciences and Histogen, has a proven track record in monetizing important cell-based therapies and bioengineered tissue technologies. Although it is known for taking four products from concept, through FDA approval, to market launch; and taken two companies to a NASDAQ stock exchange listing, she has had broad success in commercializing major brands that are still widely sold today by establishing partnerships and strategic business alliances with several industry giants, including: NYSE Company Allergan (recently purchased by AbbVie for $63B), NYSE company Smith & Nephew, NYSE company Medtronic, and Inamed Corporation (also owned by AbbVie).

“I am thrilled and honored to join the visionary HippoFi team and work together to transform healthcare by developing and commercializing life-changing regenerative medicine solutions for unmet medical needs,” said Gail Naughton, MBA, Ph.D – Head of Regenerative Therapeutics and Commercialization.

Dr. Naughton has served on the board of directors of several public and private companies since 1988. She currently serves as chair of the board of directors of the La Jolla Institute, executive chair of BioHIP, a member of the boards of NASDAQ, Therapeutics MD, and NYSE company CelSci, and serves on the boards of International Business and Fowler College of Business at SDSU. In addition to serving for eleven years on the board of the Toronto-based, publicly funded Center for the Commercialization of Regenerative Medicine (CCRM), she also served for several years on the bioengineering advisory board of John Hopkins, UCSD, MIT and Georgia Tech. Dr. Naughton served as dean of the College of Business Administration at SDSU from 2002 to 2011 and received her Ph.D. and MS from NYU Medical Center and an MBA from UCLA.

“Dr. Naughton is a globally recognized, accomplished entrepreneur with many proven track records, visionary talent and unparalleled experience that will be extremely valuable to HippoFi’s continued growth and success,” said CJ Wiggins, MBA – Founder, Executive Chairman and CEO of HippoFi. “As a pioneer in our industry, adding her expertise to our experienced team not only helps us quickly commercialize and monetize our patented technologies, but also validates the tremendous market value of our patent portfolio and strengthens HippoFi as a leader in the market for regenerative therapies. ”

About PUR Biologics
PUR Biologics, a wholly owned subsidiary of HippoFi, Inc. (OTCPK: ORHB), is a leading biologics company committed to supporting surgeons and hospitals in providing the best care to their patients. PUR Biologics’ full line of biological products currently includes: advanced allografts and demineralized extracellular matrices (dECM), innovative synthetic solutions, cellular-derived tissues and a future of next-generation regenerative stem cell and growth factor-driven therapies for the treatment of osteoarthritis and cartilage regeneration.

About HippoFi, Inc.
HippoFi, Inc. delivers its breakthrough healthcare innovations through an extensive sales channel network while deploying first-to-market solutions in the multi-billion dollar biotech, fintech and artificial intelligence (AI) markets. HippoFi consists of three segments: Regenerative Therapeutics, Digital Payments and AI, which use the same customer channels to commercialize solutions, increase revenue and improve patient outcomes.

HippoFi, Inc. is publicly traded under the symbol: ORHB and is headquartered in Irvine, California. For more information, please visit: www.HippoFi.com and www.PURbiologics.com.

Contact
HippoFi, Inc.
949-323-2330
info@hippofi.com

Source link

Similar Posts

  • Bone Health and Fractures – Food for Healthy Bones

    Article reposted with permission from Dr. Lani Simpson: https://lanisimpson.com/blogs/news Article Summary: • Fractures can be a sign of poor bone health, although they are common. • Bones are living tissues that require a balance of resorption and formation to remain healthy. • Factors that can contribute to poor bone health include age, gender, genetics, diet…

  • Best ice machine for knee surgery (Game Ready, Polar Care)

    What if you could recover from knee surgery with less pain and fewer medications? This question is at the heart of modern post-operative care. Managing discomfort and swelling is a major challenge after an orthopedic procedure. cold therapy system Cold therapy offers a powerful, drug-free solution. It is a non-invasive method to control inflammation and pain directly at the source. Specialized units deliver consistent cooling to the affected area. This can significantly reduce the need for strong painkillers during the critical healing phase. We have thoroughly examined the market of recovery tools. Our guide focuses on leading systems, including various Breg Polar Care models and the Game Ready unit. Our goal is to help you navigate your options. You can find a system that fits your needs and supports a smoother, more comfortable recovery at home. Key Takeaways Cold therapy is a proven, drug-free method to manage pain and swelling after surgery. Using a dedicated cooling unit can help reduce reliance on narcotic pain medication. Popular systems like the Breg Polar Care line come in several models, such as the Cube, Kodiak, Glacier, and Wave. Game Ready is a leading unit that combines cold therapy with adjustable compression. Always consult your healthcare provider to ensure this therapy is right for your specific procedure. Selecting the right device involves considering your budget and recovery goals. Effective, consistent cooling can greatly improve comfort and outcomes during the healing process. Introduction to Knee Surgery Recovery and Cold Therapy Successfully navigating the first weeks post-surgery hinges on a structured recovery strategy. This plan must prioritize managing two key issues: discomfort and inflammation. This is where cold therapy, also called cryotherapy, becomes essential. It involves applying controlled cooling to the surgical area to reduce inflammation. After a procedure, fluid often accumulates in the joint. This swelling, known as edema, increases pressure and causes significant pain. The therapy works by constricting blood vessels. This action helps limit the amount of fluid and blood pooling at the injury site. Many surgeons now recommend a dedicated cooling device. These units provide consistent, targeted cold therapy that is far more effective than basic ice packs. Reducing swelling early is crucial. It directly supports efforts to regain a full range of motion in the knee during rehabilitation. Healthcare providers often prescribe this therapy as a safe alternative to stronger pain medications. Patients should always combine its use with specific exercise advice from a physiotherapist. This promotes healthy blood flow and ensures optimal healing. How Cold Therapy Works in Reducing Swelling and Pain Cold therapy targets the root causes of post-operative discomfort through a simple yet powerful process. It directly addresses the inflammation and pain that hinder healing. Mechanism of Action in Cold Therapy The primary mechanism involves using cold water to constrict blood vessels. This reduces blood flow and inflammation in the affected area. A dedicated unit provides a continuous, even distribution of this chilled liquid. It maintains a steady cold temperature for many hours. cold therapy mechanism Advantages Over Traditional Ice Packs Basic ice packs warm up quickly due to body heat. Their effectiveness diminishes within minutes. In contrast, a motorized therapy system eliminates frequent trips to the freezer. Its large, insulated reservoir ensures prolonged cooling. Specialized pads are designed for specific body parts. They deliver targeted cold therapy exactly where needed. This approach prevents the condensation issues of melting ice packs. It keeps the surgical site clean and dry, enhancing comfort and hygiene. Overview of Cold Therapy Devices for Post-Surgical Recovery The market offers two primary types of cold therapy units, each with distinct mechanisms and benefits. Selecting the right one depends on your mobility, budget, and recovery goals. We categorize these devices into gravity-fed and motorized systems. This helps you understand which technology best suits your specific needs. Types of Devices: Motorized and Gravity-Fed Systems Gravity-fed devices, like the Aircast Cryo/Cuff, use elevation to circulate water without a motor. They are cost-effective and portable. The simple physics of elevation moves chilled liquid through the pad. Motorized systems provide constant recirculation of cold water between a cooler and the pad. This is ideal for patients with limited mobility after a procedure. Brands like Breg Polar Care circulate water directly for efficient cooling. The DonJoy IceMan series uses dual pump technology for a comfortable temperature. Some advanced therapy units, such as the Ossur Cold Rush, feature an adjustable flow dial. This allows patients to customize their experience. Understanding these mechanical differences is key before making a purchase. Both types deliver effective cold therapy, but their operation varies. Key Features to Consider When Purchasing an Ice Machine Several practical factors determine how well a cold therapy machine will serve you at home. The right features enhance both effectiveness and convenience during your healing period. Consistency, Coverage, and Temperature Control Look for a unit that maintains a steady cold temperature. Consistent cooling is vital for safe, prolonged sessions. Good coverage means the pad fits your joint properly. This ensures the therapy reaches all affected areas. Adjustable controls let you fine-tune the intensity. This prevents skin irritation while maximizing comfort. cold therapy…

  • |

    Epidemiology and clinical features of interstitial lung disease in patients with rheumatoid arthritis from the JointMan database

      Data source Patient demographics and disease characteristics were retrospectively analyzed after data extraction from the Discus Analytics JointMan database, a large US electronic health record-based dataset initiated in March 2009. The JointMan database includes > 17,000 rheumatology patients covered by commercial, Medicare, or Medicaid insurance. plan. Practices in the following eight states are included:…

  • |

    Management of complex regional pain syndrome (CRPS)

      By Russell Seemler, South Chandler Clinic Living with Complex Regional Pain Syndrome (CRPS) can be a challenging and disabling experience. However, physiotherapy can tackle CRPS. Physiotherapy is an essential part of the overall treatment plan for CRPS and is usually tailored to the specific needs of the individual and the severity of their condition….

  • 4 free tools for a healthy holiday – better bones

      In my house, Thanksgiving consists of family and friends gathering for a mega cooking event and the pie baking competition that happens once a year. This Thanksgiving, more than ever, we will pause and appreciate our good health and many blessings. Starting this holiday season, I also want to take a moment to appreciate…

  • Aurora Spine announces the closure of private placement financing

      Carlsbad, California, October 23, 2023 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSX VENTURE: ASG) (OTCQB: ASAPF) is pleased to announce that it has completed a non-brokered private placement of units (“Units”) at gross proceeds of approximately CDN$1.9 million (the “Offering”). As a result of the Offering, the Company issued…

Leave a Reply

Your email address will not be published. Required fields are marked *